STZ‐induced type I diabetes mellitus (DM) models have been developed in rodents for decades by depleting the insulin‐producing β‐cells in the pancreas, thereby causing hyperglycemia with a low insulin level.1, 3. The gene discussed is INS; the disease is Hyperglycemia.